Provectus Biopharmaceuticals, Inc.
| OTC Markets: PVCT
Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company, which specializes in developing oncology and dermatology therapies. Its oncology focus is on melanoma, breast cancer and cancers of the liver. The company's dermatological drug PH-10 also targets abnormal or diseased cells, with the current focus on psoriasis and atopic dermatitis. Provectus has recently completed its Phase 2 trials of PV-10 and of PH-10. Provectus Biopharmaceuticals was founded on May 1, 1978 and is headquartered in Knoxville, TN.